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Highlights 
 8% of surveyed veterinary personnel carried MRSA 
 MRSA carriage in veterinary personnel was not shared by their pets or patients 
 7% of canine patients and 8% veterinary-owned dogs carried MRSP 
 Patients and veterinary-owned dogs did not share the same clones of MRSP 















This study investigated the transmission cycle of methicillin-resistant Staphylococcus aureus (MRSA) 
and Staphylococcus pseudintermedius (MRSP) in small companion animal veterinary practice. 
Sampling was undertaken at two small animal veterinary hospitals in Sydney, Australia. Samples 
were collected from 46 veterinary personnel, 79 personnel-owned dogs and cats, 151 clinically 
normal canine hospital admissions and 25 environmental sites. Nasal swabs were collected from 
veterinary personnel. Nasal, oral and perineal swabs were collected from animals. Methicillin 
resistance was detected by growth on BrillianceTM MRSA 2 Agar and confirmed by cefoxitin and 
oxacillin broth microdilution for S. aureus and S. pseudintermedius, respectively. MRSA and MRSP 
isolates were characterised using whole genome sequencing including mecA gene screening and 
multilocus sequence typing. MRSA was isolated from four (8%) veterinary personnel but no animals. 
MRSP was isolated from 11/151 (7%) of canine hospital admissions and 4/53 (8%) of personnel-
owned dogs but no veterinary personnel or cats. No MRSA or MRSP was isolated from the 
environment. MRSP isolates were resistant to significantly more antimicrobial classes than MRSA. 
The main MRSP clone carried by canine patients (ST496) was distinct to that carried by personnel-
owned dogs (ST64). One veterinary nurse, who carried Panton Valentine leucocidin-positive ST338 
MRSA, also owned a ST749 MRSP-positive dog. Besides MRSP-positive dogs from the same 
household sharing the same clone of MRSP, MRSA and MRSP were not shared between humans, 
animals or environment. Therefore, in the non-outbreak setting of this study, there was limited MRS 
transmission between veterinary personnel, their pets, patients or the veterinary environment. 
 
Keywords: Antimicrobial resistance, staphylococci, MRSA, MRSP, companion animals, veterinary, 
zoonosis, One Health, infection control 
 
Introduction 
Staphylococcus aureus in humans and Staphylococcus pseudintermedius in dogs commonly cause 











However, the rise of methicillin-resistant S. aureus (MRSA) and S. pseudintermedius (MRSP) makes 
these bacterial infections difficult to treat with commonly available antimicrobials. Although MRSA is 
a significant pathogen for humans, it can cause disease in animals and has been isolated from a 
number of skin and soft tissue infections in Australian cats and dogs (Worthing et al., 2018a). The 
lineages of MRSA found in Australian animal species are similar to those found in Australian 
veterinarians treating these animal species (Groves et al., 2016; Worthing et al., 2018a). The 
majority of MRSA found in companion animals originate from human healthcare-associated lineages 
(Harrison et al., 2014; Worthing et al., 2018a). Human physicians occasionally attribute pets as the 
source of MRSA infections in their owners (Manian, 2003), yet it appears that MRSA can move 
between humans and animals in a bi-directional manner. Veterinarians who treat companion 
animals are at higher risk of MRSA carriage than pet owners (Loeffler et al., 2010) or veterinarians 
who do not treat animals (Jordan et al., 2011). Veterinarians can also occasionally be the source of 
MRSA infections in their patients (Walther et al., 2008; Ishihara et al., 2010). 
The epidemiology of S. pseudintermedius transmission between animals and humans is not well 
characterized. MRSP can certainly be carried by healthy pets (Bean and Wigmore, 2016), their 
owners (Gomez-Sanz et al., 2013) and veterinarians (Paul et al., 2011), and it can occasionally cause 
infections in immune-compromised people (Starlander et al., 2014). Although studies have 
documented concurrent carriage of MRSP and MRSA in veterinary dermatologists and their own 
pets (Morris et al., 2010), no studies have assessed carriage by non-dermatologist veterinarians and 
their pets. Veterinary personnel often bring their pets to their place of work thereby potentially 
exposing them to environmental and patient-associated organisms. Veterinary hospital visits and 
having an owner who works in healthcare are respective risk factors for MRSP and S. aureus carriage 
in dogs (Boost et al., 2008; Nienhoff et al., 2011), so it follows that pets owned by veterinary 
personnel may also be at increased risk of MRSA and MRSP carriage. 
The prevalence of methicillin-resistant Staphylococcus (MRS) carriage in veterinary patients is 
variably reported, with MRSA and MRSP carriage in dogs sampled in their homes in the USA 











admissions in Portugal was 6.2% (Couto et al., 2011). MRSP carriage rate is much higher in dogs with 
clinical pyoderma, with reports ranging from 33% in the USA (Detwiler et al., 2013) to over 60% in 
reports from Japan (Kawakami et al., 2010). No MRSP was found in two Australian studies conducted 
between 2004 and 2007 (Malik et al., 2006; Gottlieb et al., 2008) while a 2016 study found two of 
117 canine obedience school attendees were MRSP carriers (Bean and Wigmore, 2016). Although 
the methodology and results of veterinary MRS carriage studies vary, most studies show a steady 
upward trend of antimicrobial resistance in S. pseudintermedius as time progresses (Moodley et al., 
2014), and global expansion of a relatively small group of MRSP lineages (Perreten et al., 2010). A 
recent Australian study revealed that the most common clone of MRSP amongst clinical samples 
from animals was ST71, which is similar to the rest of the world (Perreten et al., 2010; Worthing et 
al., 2018b), but the lineages of MRSP found amongst clinically normal dogs in Australia is as-yet 
unknown. 
Molecular typing has shown that MRSA and MRSP found in the environment can be closely related 
to that carried by veterinary personnel and patients (Loeffler et al., 2005; Feßler et al., 2018). There 
is a growing body of literature investigating the transmission cycle of MRS in veterinary practice but 
no studies have concurrently examined MRSA and MRSP carriage in veterinary personnel, personnel-
owned animals, patients and the veterinary hospital environment. This study therefore aimed to 
determine the prevalence of methicillin-resistant staphylococci amongst veterinary personnel, 
personnel-owned pets, hospital patients and environment of two small animal hospitals and to use 
molecular methods to determine the relatedness of MRS isolated from these groups. 
Materials and methods 
Sampling 
Sample collection involved two veterinary hospitals in Sydney, Australia: a primary accession small 
animal hospital (Hospital A) and a multi-disciplined small animal referral hospital (Hospital B).  
Samples were collected from veterinary personnel, personnel-owned pets, canine hospital 











approved by the Human and Animal Ethics Committees at the University of Sydney (Project numbers 
2016/837, 2016/1072 and 2015/866, respectively). 
Veterinary personnel and their pets 
Sampling of veterinary personnel and their pets (dogs and/or cats) was undertaken over a two-week 
period in February 2017 (Hospital A) and April 2017 (Hospital B). Veterinary personnel included 
veterinarians and support staff (veterinary nurses, kennel hands and administrative staff). Personnel 
were invited to participate whether or not they had pets at home. Personnel were given written and 
verbal instructions on how to take samples, then took samples from themselves and their pets, 
undertaking sampling in their own home. For veterinary personnel, a single sterile swab was used to 
sample one nostril. For pet dogs and cats, personnel took three separate swabs: one each from the 
anterior nares (large dogs) or nasal planum (small dogs and cats), oral cavity and perineum. For 
multipet households, sampling was limited to three dogs and/or three cats. Personnel wore gloves 
during the procedure and refrigerated samples immediately after sampling. All swabs were collected 
using AmiesTM Agar Gel swabs (Copan Diagnostics, USA). 
Canine hospital admissions 
Swabs were taken from the nares/nasal planum, oral cavity and perineum of canine hospital 
admissions from both veterinary hospitals. Convenience sampling of canine hospital admissions 
occurred in two sampling periods in August 2015 and August 2016 for Hospital A while sampling was 
sporadic from April 2016 to April 2017 for Hospital B. To minimise sampling from dogs with known 
MRSP carriage risk factors such as recent hospitalisation or antimicrobial treatment (Nienhoff et al., 
2011), dogs had to meet the following selection criteria: a) they had been in the hospital for less 
than 10 minutes at the time of sampling (not including time spent in the waiting room); b) they were 
admitted for an elective procedure (for example: non-emergency surgery, routine blood tests, 
imaging, dentistry, boarding); c) they were deemed systemically well by the attending clinician; and 












Environmental sampling was undertaken at Hospital A only, on the same day in February 2017 that 
samples were collected from personnel and their pets. Twenty-five swabs were taken from the 
following areas: cage floors and walls, waiting room chair legs and seats, door handles into the 
consultation, treatment, pharmacy, bathroom, radiology and boarding rooms, and computer 
keyboards and computer mice in the consulting, treatment and radiology rooms. Samples were 
taken by pre-moistening AmiesTM Gel agar swabs with sterile saline, then rolling the swab across the 
environmental surface for 10sec. Although MRSP-positive carriers and patients with MRSP-infected 
wounds were known to have been in the hospital within the last month, no known MRSP carriers or 
patients were present at the time environmental sampling. Therefore, it was assumed that 
environmental sampling was indicative of a non-outbreak setting for the hospital. 
Phenotypic methicillin resistance screening 
Human, animal and environmental swabs were all processed as follows. Samples were initially 
enriched by inoculation onto 2% Columbia sheep blood agar (SBA) (Oxoid, UK) and overnight 
incubation at 37°C. If swarming colonies (presumed to be Proteus spp.) were noted after initial 
incubation, the swab was replated onto 4% SBA to allow easier subculturing of colonies with the 
morphologic appearance of staphylococci. After the enrichment step, a sterile microbiological loop 
was streaked across the blood agar plate to collect many colonies which were then subcultured onto 
the selective medium, BrillianceTM MRSA 2 Agar (Oxoid, UK) and incubated overnight at 37°C 
(Horstmann et al., 2012). Samples that grew as blue colonies on the BrillianceTM agar underwent 
catalase and tube coagulase testing. Coagulase-positive BrillianceTM-positive isolates underwent 
species confirmatory testing with MALDI-TOF mass spectrometry (BDTM Bruker MALDI BiotyperTM) as 
previously described (Worthing et al., 2018b). Phenotypic methicillin resistance was confirmed using 
the Vitek 2TM automated antimicrobial susceptibility testing (AST) system (bioMerieux, USA). 
Methicillin resistance in S. aureus was identified by a cefoxitin MIC of ≥8mg/L and in S. 
pseudintermedius by an oxacillin MIC of ≥0.5mg/L (Saputra et al., 2017). Isolates also underwent 
testing by Vitek 2TM to the following antimicrobials: benzylpenicillin, enrofloxacin, erythromycin, 











sulfamethoxazole. Clindamycin testing included screening for inducible clindamycin resistance and 
measurement of MIC by Vitek 2TM. Clinical breakpoints were used as described by the Clinical and 
Laboratory Standards Institute (CLSI, 2013a; CLSI, 2013b). Isolates with intermediate resistance were 
defined as resistant. 
Molecular characterisation of methicillin-resistant isolates 
Phenotypic MRSA and MRSP underwent whole genome sequencing (WGS) using the MiSeq system 
(Illumina, USA) as previously described (Worthing et al., 2018a; Worthing et al., 2018b). De novo 
assembly was performed CLC Genomics Workbench (Qiagen, USA). Multilocus sequence typing 
(MLST) was undertaken by uploading de novo contigs onto the respective MRSA and MRSP online 
MLST platforms hosted by the Center for Genomic Epidemiology 
(https://cge.cbs.dtu.dk/services/MLST/) (Larsen et al., 2012). New MRSP sequence types were 
assigned by the S. pseudintermedius database curator (vincent.perreten@vetsuisse.unibe.ch). All 
isolates were screened for the mecA gene, its homologues and the Panton-Valentine leucocidin gene 
(pvl) using the bioinformatics websites, ResFinder (https://cge.cbs.dtu.dk//services/ResFinder/) 
(Zankari et al., 2012) and (https://cge.cbs.dtu.dk/services/VirulenceFinder/) (Joensen et al., 2014), 
respectively. SCCmec, dru and spa typing was undertaken using sequence data as previously 
described (Worthing et al., 2018a; Worthing et al., 2018b). A phylogenetic tree of MRSP isolates was 
generated using CSI Phylogeny 1.4 (https://cge.cbs.dtu.dk/services/CSIPhylogeny/) (Kaas et al., 
2014). This program used a Maximum Likelihood algorithm to depict inferred phylogeny based on 
concatenated alignment of high quality single nucleotide polymorphisms. To construct the tree, 
fasta files of all MRSP genomes were uploaded to the online platform which aligned them to a 
reference genome (ST71 MRSP 081661, Accession number: CP16073.1 (Riley et al., 2016)). FigTree 
1.4.3 (Rambaut, 2012) and interactive tree of life (iTOL) (Letunic and Bork, 2016) were used to 












Based on previously reported MRS prevalence rates amongst Australian dogs of between 1% (Malik 
et al., 2006; Bean and Wigmore, 2016) and 11.5% (Worthing et al., 2018b), power analysis suggested 
a sample size of at least 164 would be required to predict MRS carriage frequency with 95% 
confidence (http://clincalc.com/stats/Sample Size.aspx). Categorical comparisons were undertaken 
by constructing contingency tables and performing Fishers exact test (GraphPad Prism 7, USA). 
Results were considered significant if p<0.05. 
Results 
MRSA and MRSP in humans, animals and environment 
Samples were collected from 46 veterinary personnel (19 veterinarians, 22 nurses, 2 receptionists, 3 
kennel hands), 79 personnel-owned pets, 151 canine hospital admissions and 25 environmental 
sites. This resulted in 191 samples from Hospital A (118 canine hospital admissions, 21 veterinary 
personnel, 13 personnel-owned pet dogs, 14 personnel-owned pet cats and 25 environmental sites) 
and 110 samples from Hospital B (33 canine hospital admissions, 25 veterinary personnel, 40 
personnel-owned pet dogs and 12 personnel-owned pet cats). The proportions of methicillin-
resistant staphylococci (MRS) isolated from humans, animals and the environment are shown in 
Table 1.  MRS were isolated from 4/46 veterinary personnel (8%), 11/151 (7%) canine hospital 
admissions, and 4/53 personnel-owned pet dogs (8%) but not from any cats or the veterinary 
environment. No MRSA was isolated from animals nor MRSP from humans. The MRS carriage rate in 
personnel-owned dogs was not significantly different to personnel-owned cats (p= 0.3). MRS 
frequency was proportional to sampling intensity from each hospital and was not significantly 
different between Hospital A and B (p= 0.91). Consequently, results from both hospitals were 
combined for analyses. The phenotypic antimicrobial resistance profile of all isolates is shown in 
Table 2. MRSP isolates were resistant to significantly more antimicrobial classes than MRSA 
(p<0.001). All personnel- and animal-derived MRS samples underwent WGS and in silico molecular 
characterisation (Table 3). Two Brilliance-positive isolates (one S. aureus (KW8) and one S. 











screening. It was assumed that a methicillin-susceptible subpopulation had been inadvertently 
subcultured for AST testing and thus these two isolates were still included in further analyses. The 21 
genomes obtained from whole genome sequencing have been deposited at the National Center for 
Biotechnology Information (NCBI) database, under Bioproject accession number PRJNA482500. 
Characterisation of MRSA from veterinary personnel 
Of the four MRSA isolates from veterinary personnel, three were from veterinarians and one was 
from a veterinary nurse. MRSA carriage amongst veterinarians (16%) was not significantly different 
to support staff (4%; p= 0.29). Three of the four MRSA isolates were susceptible to all non-β-lactam 
antimicrobials. The fourth isolate, ST338 from a veterinary nurse (Table 3), was additionally resistant 
to tetracycline. One veterinarian from each of the hospitals carried ST59-IV MRSA. The two isolates 
were different spa types (t316 and t976). One MRSA isolate, ST338 SCCmec type V isolate from a 
veterinary nurse, harboured the Panton-Valentine leucocidin gene (pvl); the remaining isolates were 
pvl-negative. The final MRSA isolate, ST81 from a veterinarian, was phenotypically susceptible to 
oxacillin but harboured the mecA gene. Post-hoc power analysis found that with a sample size of 46, 
previously reported Australia-wide veterinarian MRSA carriage rate of 4.8% (Jordan et al., 2011) and 
observed MRS frequency rate of 8%, the personnel-sampling component of the study was 
underpowered (power= 23%). A sample size of 409 would have been required to obtain 80% power 
in the veterinary personnel component of the study. 
Characterisation of MRSP from personnel-owned pets and canine hospital admissions 
The MRSP carriage rate between personnel-owned pet dogs and canine hospital admissions was not 
significantly different (p= 0.77). Two main MRSP lineages were isolated: ST496 (n= 6) and ST64 (n= 
6). ST496 was the most common clone amongst canine hospital admissions (6/12 dogs; 50%) but 
was not carried by any personnel-owned dogs. ST64 was the most common clone amongst 
personnel-owned dogs and was carried by all three personnel-owned dogs at Hospital B. Within 
each of the hospitals, none of the personnel-owned dogs carried the same clone as hospital 











and dru type (t05 and dt10a respectively) but subsequent isolates from later years and from Hospital 
B showed different dru and spa types (Table 2). Figure 1 shows the phylogeny of MRSP isolated from 
canine hospital admissions and personnel-owned dogs at both hospitals. Isolates clustered within 
their respective MLST lineages and isolates within MLST tended to cluster according to hospital, 
suggesting a degree of geographic clustering. 
Shared MRS carriage in veterinary personnel and their pets 
Of the 46 veterinary personnel that were sampled, 38 also had their pets sampled. Of the 38 
personnel-pet groupings, concurrent MRS carriage was identified in one veterinary nurse and one of 
the two dogs owned by that nurse. The isolate from the nurse was ST338 MRSA with SCCmec type V 
while the nurse’s pet dog carried ST64 MRSP with a mec complex type C1/ccrC6 SCCmec element. 
Besides both SCCmec elements carrying a type C1 mec gene complex, the nurse- and pet- derived 
MRS samples did not appear related. Two pairs of dogs from the same household were both MRSP 
carriers. The first pair were personnel-owned dogs from Hospital B. Both dogs carried ST64 which 
clustered closely in the phylogenetic tree. The dog’s owner, a veterinarian, was not a MRS carrier. 
The second MRSP-positive pair were hospital admissions at Hospital A, admitted on the same day for 
routine dental care. The ST496 MRSP isolated from this pair clustered closer to each other than 
other ST496 isolates. 
Discussion 
This study detected MRSA amongst veterinary personnel and MRSP in dogs but did not find MRSP 
carriage in humans, MRSA carriage in animals, or any MRS in the environment. The absence of MRSA 
in animals and MRSP in humans supports the notion that S. aureus is generally more host-adapted to 
humans and S. pseudintermedius to dogs (Simou et al., 2005). Four of 46 veterinary personnel (8%) 
were MRSA carriers. Our results add to evidence that the rate of MRSA carriage in veterinary 
personnel, like human healthcare workers, is higher than what is reported in the general population 
(Moodley et al., 2008; Loeffler et al., 2010; Jordan et al., 2011; Eveillard et al., 2015). The three 










commonly reported MRSA lineages isolated from human hospitals in Sydney in the same time 
period, and the level of antimicrobial resistance to non--lactam antimicrobials was lower than 
healthcare associated MRSA clones in Sydney (Australian Commission on Safety and Quality in 
Health Care, 2017). The level of antimicrobial resistance amongst MRSA in this study was also lower 
than the resistance seen in ST22 MRSA, which is the lineage most commonly isolated from small 
animal veterinarians (Groves et al., 2016; Loeffler et al., 2005). The veterinary-specific risk factors for 
MRSA carriage are not yet known, but it is possible that veterinary personnel have similar 
occupational risk factors to workers in healthcare such as caring for patients with MRSA-infected 
wounds (Cox and Conquest, 1997). However, MRSA appears to be much more prevalent amongst 
human hospital patients than veterinary hospital patients, so it is likely that additional risk factors 
exist for veterinarians such as the handling of antimicrobial drugs (Moodley et al., 2008; Morris et 
al., 2010), or environmental exposure to biocides and patient-excreted antimicrobials. It is clear that 
an extensive prospective cross-sectional study is warranted to better define the occupational risk 
factors for MRSA carriage in veterinary personnel. 
The rate of MRSP carriage amongst personnel-owned dogs (8%) was not significantly different to 
canine hospital admissions (7%), indicating that dogs of veterinary personnel are not at increased 
risk of MRSP or MRSA carriage compared to canine hospital admissions from the same geographic 
area. Previous studies have found that pets owned by human healthcare workers are at increased 
risk of carrying methicillin-susceptible S. aureus (MSSA) (Boost et al., 2008), but there are conflicting 
reports as to whether or not dogs owned by healthcare workers are at increased risk of MRSA 
carriage (Boost et al., 2008; Kottler et al., 2010). Future studies that directly compare the relative 
risk of MRSA and MRSP carriage amongst pets owned by veterinary personnel, human healthcare 
workers and non-healthcare workers are now warranted. All three MRSP-positive personnel-owned 
dogs at Hospital B carried ST64 which closely clustered on the phylogenetic tree and differed by less 
than 100 SNPs, suggesting that ST64 had circulated amongst personnel-owned pets in this hospital. 











discharge would have helped to determine whether canine hospital admissions subsequently 
acquired MRSP lineages carried by personnel-owned pets in the same hospital. 
The rate of 7% MRSP carriage we found amongst canine hospital admissions is similar to some 
previous studies (Nienhoff et al., 2011), but higher than the 1% MRSP carriage rate in another 
Australian study that examined healthy dogs at an obedience school in regional Victoria (Bean and 
Wigmore, 2016). The difference could reflect increased local prevalence in Sydney compared to 
regional Victoria or increased prevalence amongst dogs attending veterinary hospitals compared to 
obedience school. ST496, a multidrug resistant MRSP strain, was the most common clone carried by 
canine hospital admissions in this study and was also the most common clone amongst clinical MRSP 
from dogs in greater Sydney in 2013 (Worthing et al., 2018b).  ST496 has not yet been reported 
outside Australia, but ST496 has become a common clone in Sydney that has evolved and diversified, 
evidenced by a greater diversity of dru types in this study compared to the 2013 surveillance study 
(Worthing et al., 2018b). Concurrent carriage of ST496 MRSP by two canine hospital admissions from 
the same household suggested intra-household transmission had occurred. Although neither patient 
showed signs of skin disease at the time of sampling, inspection of both patients’ records revealed 
that one of the dogs had a long history of intermittent antimicrobial use to treat pyoderma 
secondary to flea allergy dermatitis. It is likely that the dog with a history of skin disease acted as a 
source of MRSP for the asymptomatic dog in the same household (Duijkeren et al., 2011; Laarhoven 
et al., 2011). While clear risk factors for MRSP carriage and infection such as previous antimicrobial 
use, frequent veterinary visits and a history of hospitalisation have already been identified (Nienhoff 
et al., 2011; Lehner et al., 2014), veterinarians should be aware that apparently healthy dogs can 
also carry MRSP, particularly if they live with an MRSP carrier. 
It is noteworthy that the MRSP isolates in this study displayed a significantly higher level of 
antimicrobial resistance than the MRSA isolates, with 37% resistance to fluoroquinolones and 
trimethoprim-sulfamethoxazole and 32% resistance to erythromycin amongst MRSP compared to no 
resistance to these classes amongst MRSA isolates. While MRSP is not a major zoonotic pathogen, 











health concern because such lineages may act as a reservoir for genetic resistance determinants. 
Animal-derived staphylococci can be the source of resistance determinants in human S. aureus (Rolo 
et al., 2017), but the extent to which S. pseudintermedius contributes to the resistance gene pool in 
human pathogens such as S. aureus is not fully determined (Frank et al., 2009) and could thus be 
examined in future genomic studies. 
Besides concurrent MRSA carriage in a veterinary nurse and MRSP carriage in the nurse’s pet dog, 
this study found no shared MRS carriage in veterinary personnel and their pets. The lack of MRSP 
isolation from veterinary personnel in this study likely reflects the general lack of human host 
tropism by MRSP but could also reflect the small sample size and the fact that animals with overt 
skin disease were intentionally omitted from this study. Additionally, MRSP has recently been 
isolated from the hands of veterinary personnel (Feßler et al., 2018), so the sensitivity of our study 
may have been improved had we included hand as well as nasal sampling of humans. Dogs with skin 
disease are more likely to carry MRSP than dogs with healthy skin (Griffeth et al., 2008), and 
transmission of MRSP from animals to owners is more commonly reported when the animal has 
clinical disease (Duijkeren et al., 2011). Certain MRSP lineages such as ST71 appear better able to 
colonize human corneocytes than MSSP or other MRSP lineages and thus may have better zoonotic 
potential (Latronico et al., 2014). It is therefore possible that the lack of human MRSP carriage in this 
study reflects the lack of ST71 in the animal population sampled. Although ST71 is a dominant MRSP 
clone in Europe (Perreten et al., 2010) and represents 34% of clinical MRSP in Australia overall 
(Worthing et al., 2018b), it was not isolated from any dogs in this study and was isolated from only 
1/24 (4%) clinical MRSP cases around Sydney in 2013 (Worthing et al., 2018b). Overall, it appears 
that MRS carriage by veterinary personnel is influenced by their role within the veterinary hospital 
and the local prevalence and clonal distribution of MRS in their respective patient population. 
MRSP was not isolated from the veterinary hospital environment. This could be attributed to the low 
sample size, the lack of longitudinal sampling, or the fact that equipment with high animal contact 
from which MRSP has been isolated in other studies, such as clippers (Feßler et al., 2018) or feeding 











protocol for the management of known MRS-infected patients which was initiated six months prior 
to this study which may have effectively reduced the MRS load in the environment. Successful 
reduction of environmental MRSA was reported in a human hospital that revised its hospital 
infection control protocols to address an increase in MRSA cases (Rampling et al., 2001), but lack of 
longitudinal sampling pre- and post-cleaning protocol prevents us from assessing whether the 
absence of MRSP was truly due to a successful infection control program. 
This study provides valuable insights into the molecular epidemiology of MRS within two veterinary 
hospitals. The clonal types of MRSP and MRSA found in veterinary personnel, personnel-owned pets 
and hospital admissions were distinct from each other. This suggests that limited MRS transmission 
occurs between these groups, at least in a non-outbreak setting as was examined in this study. The 
rate of MRS isolation was not significantly different between the tertiary referral hospital and a 
primary accession hospital, nor between personnel-owned dogs and hospital admissions. MRSP 
carriage was not detected amongst veterinary personnel. However, it is apparent that clonal types of 
MRSP vary with geography, so sampling of dogs and veterinary-personnel in areas where ST71 MRSP 
is common would provide valuable comparative results for this study. Contrasting with the lack of 
MRSP carriage in our study, MRSP carriage has been twice documented in veterinary dermatologists 
(Morris et al., 2010; Paul et al., 2011). A study that simultaneously compares MRSP carriage amongst 
dermatologist and non-dermatologist veterinarians is warranted to evaluate whether specialty-
specific risk for MRSP carriage exists amongst veterinarians. Lastly, our study adds to existing 
literature in reporting that veterinarians have a higher rate of MRSA carriage than the general 
population. A large-scale case-control study is thus warranted to further investigate the occupational 
risk factors for MRSA carriage in veterinarians. 
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Table 1. Methicillin-resistant coagulase- positive staphylococci isolated from veterinary personnel, canine 
hospital admissions, personnel-owned pets and the veterinary hospital environment 
Group Number sampled Number of carriers (%) 
  MRSA MRSP 
Veterinary personnel    
Veterinarians 19 3 (16%) 0 
Support staff 27 1 (4%) 0 
Total personnel 46 4 (8%) 0 
Dogs    
Hospital admissions 151 0 11 (7%) 
Personnel-owned 53 0 4 (8%) 
Total dogs 204 0 15 (8%) 
Cats    
Personnel-owned 26 0 0 
Hospital environment    
Waiting room chairs 2 0 0 
Door handles 8 0 0 
Computer keyboards 3 0 0 
Cage door handles 3 0 0 
Cage interiors 9 0 0 
Total environment 25 0 0 
Total samples 301 4 (1%) 15 (5%) 
Table 2. Frequency (%) of antimicrobial resistance in MRSA and MRSP from veterinary hospitals 
Group PEN ENR ERY CLI TET CHLOR RIF TMS 
MRSP (n=15) 100 37 32 16 58 42 0 37 
MRSA (n= 4) 100 0 0 0* 25 0 0 0 
PEN= benzylpenicillin, ENR= enrofloxacin, ERY= erythromycin, CLI= clindamycin, TET= tetracycline, 
CHLOR= chloramphenicol, RIF= rifampicin, TMS= trimethoprim-sulfamethoxazole. *Susceptible to 











Table 3. Molecular epidemiology MRSA and MRSP isolated from veterinary personnel, personnel-owned dogs and canine hospital 
admissions in Sydney, Australia 
Isolate Year 
isolated 




MLST SCCmec Spa type Dru type 
HOSPITAL A          
KW12 2017 Veterinarian MRSA Nares + ST59 IV t316 None 
KW1606a 2015 Dog (H) MRSP Nares and 
perineum 
+ ST496 Vt t05 dt10a 
KW1610a 2015 Dog (H) MRSP Nares, oral cavity 
and perineum 
+ ST496 Vt t05 dt10a 
KW1608 2015 Dog (H) MRSP Perineum + ST496 Vt t05 dt10a 
KW1614 ± 2015 Dog (H) MRSP Perineum + ST525 Vt t09 dt9bd 
KW1613 ± 2015 Dog (H) MRSP Oral cavity + ST68 Vt t23 New 
KW1607 2015 Dog (H) MRSP Nares + ST64 C1/ccrC6 None dt7ae 
KWAH3 2016 Dog (H) MRSP Oral cavity + ST496 Vt t05 New 
KWAH4 2016 Dog (H) MRSP Oral cavity and 
perineum 
+ ST496 Vt t02 New 
KWAH1 2016 Dog (H) MRSP Oral cavity + ST64 C1/ccrC6 None dt11af 
KWAH2 2016 Dog (H) MRSP Oral cavity + ST64 C1/ccrC6 None dt10cj 
KW5 2017 Dog (P) MRSP Nares - ST749 IV None NT 
HOSPITAL B          
KW7c 2017 Veterinary 
nurse 
MRSA Nares + ST338 V t441 NT 
KW8 2017 Veterinarian MRSA Nares - ST81 IV t177 dt7f 
KW3 2017 Veterinarian MRSA Nares + ST59 IV t976 dt7f 
KWBH2 ¥ 2016 Dog (H) MRSP Oral cavity and 
perineum 
+ ST751 NT None NT 
KW1 2017 Dog (H) MRSP Nares and oral 
cavity 
+ ST496 Vt t02 dt7f 
KW10b 2017 Dog (P) MRSP Nares + ST64 C1/ccrC6 None New 
KW11b 2017 Dog (P) MRSP Oral cavity + ST64 C1/ccrC6 None dt7f 
KW6c 2017 Dog (P) MRSP Nares, oral cavity 
and perineum 
+ ST64 C1/ccrC6 None New 
§ = Phenotypic methicillin resistance as determined by Vitek2 MIC testing: cefoxitin MIC for MRSA isolates; oxacillin MIC for MRSP isolates. 
± = Isolates 1613 and 1614 originated from the same dog but were different MLST types.   ¥ = Both isolates from dog KWBH2 underwent 
phenotypic and genotypic testing and both isolates were mecA positive but one isolate was resistant to oxacillin (MIC= 0.5mg/L) while the 
other was susceptible (MIC<0.25mg/L). a, b, c = Isolates with the same superscript letters originated from the same household.  Dog (H)= 
canine hospital admission; Dog (P)= personnel-owned dog. NT= not typable. Unless indicated, dogs that were positive at multiple sites 














Figure 1. Phylogenetic tree of methicillin-resistant Staphylococcus pseudintermedius from canine veterinary hospital 
admissions and personnel-owned dogs, generated using a Maximum Likelihood algorithm based on a concatenated 
alignment of 16,209 high-quality SNPs. The tree was constructed using CSIPhylogeny 1.4 and optimized using FigTree 
v1.4.3 and Interactive Tree of Life v3 (iTOL). ST71 MRSP 081661 (Accession: CP16073.1) was used as the reference 
genome. Circles indicate isolates from personnel-owned dogs. Squares indicate isolates from canine hospital admissions. 
Blue shapes are from Hospital A, orange shapes are from Hospital B. The MLST of each isolate is shown on the right-
hand margin of the tree. * = indicates a pair of isolates from two dogs in the same household. 
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